Case Details
- Citation: [2014] SGHC 178
- Title: Culindo Livestock (1994) Pte Ltd v Ananda UK (China) Limited
- Court: High Court of the Republic of Singapore
- Date of Decision: 10 September 2014
- Case Number: Suit No 357 of 2012
- Judge: Tay Yong Kwang J
- Plaintiff/Applicant: Culindo Livestock (1994) Pte Ltd
- Defendant/Respondent: Ananda UK (China) Limited
- Counsel for Plaintiff: Tito Shane Isaac and Justin Chan (Tito Isaac & Co LLP)
- Counsel for Defendant: Sankaran Karthikeyan (Toh Tan LLP)
- Legal Area: Commercial Transactions – Sale of Goods
- Core Contract Issue: Contractual terms; implied conditions under the Sale of Goods Act
- Statutes Referenced: Sale of Goods Act (Cap 393, 1999 Rev Ed) (“SGA”)
- Other Statutes Referenced (as argued): Evidence Act (Cap 97, 1997 Rev Ed) (ss 93–94) (parole evidence rule)
- Cases Cited: [2006] SGHC 242; [2014] SGHC 178 (as provided in metadata)
- Judgment Length: 20 pages, 9,897 words
Summary
Culindo Livestock (1994) Pte Ltd v Ananda UK (China) Limited concerned a commercial dispute arising from the sale of ceftiofur sodium sterile (“CSS”), an antibiotic used in livestock respiratory disease treatment. Culindo, a Singapore wholesaler of livestock-related products, purchased CSS from Ananda under 11 sales contracts concluded between 2009 and 2011. The dispute focused primarily on the tenth and eleventh contracts (dated 4 March 2011 and 6 April 2011), where laboratory testing indicated that the goods delivered did not correspond to CSS.
The High Court (Tay Yong Kwang J) held that the contractual framework engaged the Sale of Goods Act’s implied conditions, particularly those relating to correspondence with description and satisfactory quality. The court accepted that Ananda had supplied goods that were not CSS as described in the contracts, and that the goods were therefore not of satisfactory quality and did not meet the contractual description. The court allowed Culindo’s claim in part and dismissed Ananda’s counterclaim for non-payment in its entirety.
Although the parties debated whether the transaction was properly characterised as a sale by description, a sale by sample, or both, the court’s analysis ultimately turned on the nature of the contractual bargain and the statutory implied terms that followed. The decision is significant for practitioners dealing with pharmaceutical or chemical supply chains, where documentation, standards, and laboratory testing often become central to determining breach and remedy.
What Were the Facts of This Case?
Culindo had been operating since 1994 in the wholesale business of livestock. Before contracting with Ananda, Culindo purchased CSS through local and foreign intermediaries. Ananda entered the relationship after sending an introductory email offering three products, including CSS, and describing itself as a “sophisticated distributor”. Following discussions, the parties entered into 11 sales contracts over nearly two years (2009–2011) for CSS.
Each sale process was typically initiated by Culindo sending a purchase order to Ananda. In response, Ananda provided the sales contract and accompanying documents, including a commercial invoice, packing list, certificate of analysis, certificate of origin, certificate of insurance, and an air waybill. Before Culindo accepted shipments, it extracted samples from each delivery and sent them to an external laboratory, Pacific Laboratory Services (“Pacific Lab”), for testing. Pacific Lab conducted a “matching test” by comparing the samples against a reference sample provided by Chem Tec Incorporated (“Chemtec”), described as the “Chemtec standard”.
The core dispute concerned the tenth and eleventh contracts. Under both contracts, Ananda was to supply 200kg of CSS at a unit price of USD595 per kg, for a total contract price of USD119,000 each. Pacific Lab’s testing of CSS delivered under the tenth contract showed a CSS composition of 93.29%, below the Chemtec standard of 95.05%. A second sample from the same batch tested even lower at 91.86%. Under the eleventh contract, two shipments were sent and tested; one sample met the Chemtec standard at 96.15%, but the second sample produced a result of 0.26%, indicating a severe shortfall.
In response to the problems, Culindo returned approximately 150kg of CSS to Ananda around June 2011. Ananda delivered a replacement batch of 160kg, with the additional 10kg described as a goodwill gesture. However, Culindo remained concerned and sought independent verification. A Korean-based company, Woogene Biotechnology Co Ltd, approached Culindo with a proposal to supply CSS and conducted laboratory tests comparing Ananda’s CSS with its own product. Those tests suggested different chemical compositions. Culindo then had Pacific Lab test samples against the internationally recognised reference standard of Sigma-Aldrich, and it also engaged another independent laboratory, TUV SUD PSB Pte Ltd (“TUV”), to run tests against the Sigma-Aldrich standard. To preserve the integrity of the sampling process, Culindo engaged Crown Agents to extract samples from Ananda’s goods for laboratory testing.
Based on the combined test results, Culindo concluded that Ananda’s shipments for both the tenth and eleventh contracts contained little or no CSS. Further testing indicated that Ananda had supplied cefotaxime sodium (“CFX”) instead of CSS. Culindo led evidence that CFX was substantially cheaper than CSS and that CFX was mainly used to treat respiratory tract infections in humans, whereas CSS was primarily used for livestock. Culindo also attempted to resolve the issue with Ananda, including requesting true copies of the certificate of origin to show the product’s source (Canada). Culindo proposed joint extraction and laboratory tests, but Ananda refused. Instead, Ananda demanded that Culindo either return the 400kg of CSS delivered or pay for it.
What Were the Key Legal Issues?
The High Court identified several core issues. The first was classification: whether the contracts for CSS were properly characterised as sales by description, sales by sample, or both. This classification mattered because different implied conditions under the Sale of Goods Act apply depending on the nature of the sale.
Second, assuming the sale was by description, the court had to determine whether Ananda breached the implied condition under s 13(1) of the SGA that the goods would correspond with the description. Third, the court had to decide whether there was a breach of the implied condition under s 14(2) that the goods supplied would be of satisfactory quality.
Fourth, Ananda argued for implied contractual terms concerning the source and standards of CSS. Specifically, it contended that CSS was to be procured from Chemtec and that Chemtec’s certificate of analysis and standard were sufficient and intended to be used to test suitability and quality. Finally, the court had to determine the appropriate remedy given the breaches found on the facts.
How Did the Court Analyse the Issues?
The court’s analysis began with the statutory architecture of the Sale of Goods Act. Tay Yong Kwang J emphasised that determining which implied terms apply requires first ascertaining the nature of the transaction. In broad terms, s 14 of the SGA applies to sales in the course of business generally, while s 13 primarily addresses sales by description. By contrast, s 15 addresses sales by sample. The court therefore treated classification as a threshold question.
In considering whether the contracts were sales by description or by sample, the court drew on established principles. Where goods are unascertained, the buyer must have some means of knowing whether the seller’s goods are the goods specified in the contract. In such circumstances, the sale is typically by description. The court also noted a distinction between contractual words that identify the goods and those that denote quality. Words that identify the goods (for example, naming the specific chemical) tend to support a description-based analysis, whereas words that merely describe quality may be more consistent with a sample-based analysis.
On the facts, the contracts were framed around the supply of CSS, a specific antibiotic. The purchase orders and sales contracts contemplated delivery of CSS, and the accompanying documents (including certificates of analysis and origin) were part of the documentation regime supporting the transaction. Culindo’s testing regime—sending samples to Pacific Lab for matching tests against the Chemtec standard—was relevant, but the court treated it as an evidential mechanism for verifying compliance rather than as the sole basis for characterising the transaction as a sale by sample. The court’s reasoning reflected that the buyer’s right to the goods promised under the contract should not be displaced merely because testing is conducted prior to acceptance.
Having determined that the implied conditions were engaged, the court then addressed breach. On Culindo’s evidence, the goods delivered under the tenth contract fell below the Chemtec standard, and the second sample from the same batch tested even lower. Under the eleventh contract, one shipment met the Chemtec standard but the other produced a result of 0.26%, indicating a profound mismatch. More importantly, independent testing against the Sigma-Aldrich reference standard, together with further analysis, supported Culindo’s conclusion that the goods were not CSS at all, but CFX. This went beyond a mere quality shortfall; it undermined the fundamental correspondence between the contractual description (“CSS”) and the goods delivered.
Accordingly, the court found breach of the implied condition under s 13(1) that the goods correspond with the description. The court also found breach of the implied condition under s 14(2) relating to satisfactory quality. The reasoning was that goods supplied as CSS but containing little or no CSS (and instead containing CFX) could not be said to be of satisfactory quality for the buyer’s intended commercial purpose, particularly where the buyer’s business depended on reliable chemical composition for livestock treatment and where the contractual bargain was for CSS.
The court also dealt with Ananda’s attempt to imply additional contractual terms. Ananda sought to have the court treat Chemtec as the source of CSS and to treat Chemtec’s certificate of analysis and standard as sufficient to certify suitability and quality. Culindo resisted, arguing that implication was barred by the parole evidence rule and that business efficacy could not support the proposed terms. While the truncated extract does not set out the full detail of the court’s treatment of the Evidence Act arguments, the overall outcome indicates that the court did not accept Ananda’s implied-term framework as overriding the statutory implied conditions. The court’s approach reflects a common judicial reluctance to imply terms that would contradict the express contractual description or that would effectively shift the risk of non-conforming goods away from the seller when the goods delivered do not match what was contracted for.
Finally, the court considered remedy. The dispute included Ananda’s counterclaim for non-payment of the contract price for the tenth and eleventh contracts. Given the court’s findings that the goods were not CSS and were not of satisfactory quality, the practical effect was that Culindo was not obliged to pay for non-conforming goods delivered under those contracts. The court’s partial allowance of Culindo’s claim and dismissal of Ananda’s counterclaim underscores that, in sale of goods disputes, statutory implied conditions can provide a robust basis for withholding payment where the goods fail to correspond with description and quality requirements.
What Was the Outcome?
At trial, Tay Yong Kwang J allowed Culindo’s claim in part and dismissed Ananda’s counterclaim in its entirety. The court’s findings meant that Culindo succeeded in establishing breach of the relevant implied conditions under the Sale of Goods Act for the tenth and eleventh contracts, particularly in relation to correspondence with description and satisfactory quality.
Both parties subsequently appealed. However, based on the trial outcome described in the extract, the practical effect was that Culindo was entitled to relief for the non-conforming goods, while Ananda could not recover the contract price through its counterclaim for non-payment for the affected contracts.
Why Does This Case Matter?
This decision matters because it illustrates how Singapore courts apply the Sale of Goods Act’s implied conditions in complex commercial supply arrangements involving scientific testing and documentation. In industries such as pharmaceuticals, veterinary medicines, and chemical trading, parties often rely on certificates of analysis, origin documents, and laboratory matching tests. Culindo v Ananda shows that where the goods delivered do not correspond to the contractual description, the seller cannot rely on testing protocols or documentation to avoid statutory liability.
For practitioners, the case is also useful on the threshold question of whether a transaction is a sale by description or by sample. The court’s reasoning indicates that classification is not determined solely by the existence of testing. Instead, it depends on the contractual bargain and the buyer’s basis for knowing what goods are promised. Where the contract identifies the goods by name (CSS), the implied condition of correspondence with description is likely to be engaged even if samples are tested prior to acceptance.
Finally, the decision has practical implications for remedies and payment. Sellers may seek to frame disputes as payment issues or as quality disputes that can be cured or compensated. This case demonstrates that where the delivered goods are fundamentally different from what was contracted for, the buyer may be entitled to refuse payment and obtain relief. Lawyers advising either buyers or sellers should therefore focus early on how the contract describes the goods, what the implied statutory conditions require, and how laboratory evidence will be used to establish non-conformity.
Legislation Referenced
- Sale of Goods Act (Cap 393, 1999 Rev Ed), including:
- Section 13(1) – implied condition as to correspondence with description
- Section 14(2) – implied condition as to satisfactory quality
- Section 15 – sale by sample (referenced in the court’s analytical framework)
- Evidence Act (Cap 97, 1997 Rev Ed) – ss 93 and 94 (parole evidence rule) (raised by the plaintiff in argument)
Cases Cited
- [2006] SGHC 242
- [2014] SGHC 178
Source Documents
This article analyses [2014] SGHC 178 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.